Page last updated: 2024-11-05

n-methylacetamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methylacetamide is a colorless, hygroscopic liquid with a sweet odor. It is a common solvent used in organic chemistry and is also used as a plasticizer and a component of some pharmaceuticals. N-methylacetamide can be synthesized by the reaction of acetic acid with methylamine. It has been studied for its potential applications in various fields such as solvent for polymerization, a component in pharmaceutical formulations, and as a potential biofuel. It is important for its unique properties as a solvent and its potential as a sustainable alternative to more traditional solvents.'

N-methylacetamide: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-methylacetamide : A monocarboxylic acid amide that is the N-methyl derivative of acetamide. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6582
CHEMBL ID11544
CHEBI ID87321
MeSH IDM0070292

Synonyms (54)

Synonym
acetylmethylamine
NML ,
hsdb 94
methyl acetamide
n-methyl acetamide
acetic acid, amide, n-methyl
n-monomethylacetamide
einecs 201-182-6
acetamide, methyl-
ai3-18019
nsc 747
inchi=1/c3h7no/c1-3(5)4-2/h1-2h3,(h,4,5
n-methylacetamide
79-16-3
wln: 1vm1
x 44
nsc747
monomethylacetamide
nsc-747
methylacetamide
acetamide, n-methyl-
n-methylacetamide, >=99%
n-methyl-acetamide
chebi:87321 ,
CHEMBL11544
FT-0654956
M0133
n-acetyl-n-methylamine
A9897
NCGC00247922-01
dtxsid0047167 ,
cas-79-16-3
dtxcid8027167
NCGC00254149-01
tox21_300192
AKOS008933407
ec 201-182-6
unii-v0t777481m
v0t777481m ,
methyl acetamide [inci]
n-methylacetamide [hsdb]
W-104266
ch3conhch3
mfcd00008683
n-methylacetamide, purum, >=98.0% (gc)
Z32016274
n-methylacetylamine
Q12871952
n-methylacetamide;acetamide, n-methyl-;nmethylacetamide;n-methylacetamide acetamide, n-methyl- nmethylacetamide
AMY4115
n-methylacetamide(nma)
CS-0031873
PD162122
EN300-54106

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" First convincingly introduced by Baxter and Lathe in 1971, the concept that certain amides can block toxic effects of dimethyl sulfoxide (Me(2)SO) was contradicted by direct experiments in 1990."( Cryoprotectant toxicity neutralization.
Fahy, GM, 2010
)
0.36

Pharmacokinetics

ExcerptReferenceRelevance
" Area under the plasma concentration curve (AUC) values were determined for DMAC and its metabolite N-methylacetamide (NMAC), following 6-h exposures (single exposure or last in a series of 10 exposures)."( Dimethylacetamide pharmacokinetics following inhalation exposures to rats and mice.
Hundley, SG; Kennedy, GL; Lieder, PH; McCooey, KT; Valentine, R, 1994
)
0.5
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
acetamidesCompounds with the general formula RNHC(=O)CH3.
monocarboxylic acid amideA carboxamide derived from a monocarboxylic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
(aminomethyl)phosphonate degradation1231
aminomethylphosphonate degradation419

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency6.91670.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID70688Percentage of benzidine-positive murine erythroleukemia cells on day 6.1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Induction of differentiation of leukemia cells in vitro by N-substituted amides, lactams, and 2-pyridones.
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID70689Cell growth was measured on day 3, after murine erythroleukemia cells were exposed at a cell concentration of 1*10e5 cells/mL.1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Induction of differentiation of leukemia cells in vitro by N-substituted amides, lactams, and 2-pyridones.
AID70690Cell growth was measured on day 6 after murine erythroleukemia cells were exposed at a cell concentration of 1*10e5 cells/mL.1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Induction of differentiation of leukemia cells in vitro by N-substituted amides, lactams, and 2-pyridones.
AID25749Compound was evaluated for the second order hydrolysis rate constant2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
Hydrolytic stability versus ring size in lactams: implications for the development of lactam antibiotics and other serine protease inhibitors.
AID70691Concentration producing the maximum percentage of benzidine-positive cells after 6-days of continuous exposure in murine leukemia cells.1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Induction of differentiation of leukemia cells in vitro by N-substituted amides, lactams, and 2-pyridones.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (174)

TimeframeStudies, This Drug (%)All Drugs %
pre-199024 (13.79)18.7374
1990's9 (5.17)18.2507
2000's67 (38.51)29.6817
2010's69 (39.66)24.3611
2020's5 (2.87)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 59.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index59.49 (24.57)
Research Supply Index5.19 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index97.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (59.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.12%)6.00%
Case Studies2 (1.12%)4.05%
Observational0 (0.00%)0.25%
Other174 (97.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]